Please login to the form below

Not currently logged in
Email:
Password:

tumours

This page shows the latest tumours news and features for those working in and with pharma, biotech and healthcare.

Amgen reveals more data on KRAS drug

Amgen reveals more data on KRAS drug

Amgen is now moving ahead quickly with other studies of AMG 510, including a phase 2 monotherapy trial and phase 1 combination studies intended to guard against the possibility that tumours

Latest news

More from news
Approximately 8 fully matching, plus 1,035 partially matching documents found.

Latest Intelligence

  • The evolution of real-world studies The evolution of real-world studies

    Analyses of real-world tumour responses and safety data persuaded the FDA that Ibrance is safe and effective in men, leading it to expand the label.

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    These include 11 industry firsts, including the world’s first use of circulating tumour DNA to guide therapy, which decreases clinical risks associated with solid tumour biopsy, and increasing patient access ... Ruth has more than 80 publications to

  • Bringing life to precision medicine Bringing life to precision medicine

    This is due in part to a lack of available drugs specific to each oncogenic mutation, but also because tumour biology is just too complex to be characterised by individual mutations ... Patient-derived ‘organoids’: the next frontier in precision

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    TALEN is now being deployed most widely in chimeric antigen receptor T cell (CAR-T) therapies, which generally involve harvesting T cells from patients, modifying them to attack tumour cells by

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    the potential to cause tumours (pro-tumorigenic), which eventually drives disease progression. ... Pangalos. “But with CRISPR, if you have to change something in every muscle cell or in every tumour cell that’s mutated, how exactly do you do that?

More from intelligence
Approximately 0 fully matching, plus 78 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 33 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics